Altuviiio Children's Study Demonstrates Equivalent Outcomes
A yearlong study of the newly approved half-life extender showed no evidence of factor VIII inhibitors.
Source: managedhealthcareexecutive.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Weekly Factor. Real-time updates on events, politics, business and more.